NewsNew COVID-19 subvariant XEC threatens to become dominant in Europe

New COVID-19 subvariant XEC threatens to become dominant in Europe

At the end of June this year, a new variant of COVID-19 labelled XEC, was detected for the first time in Germany and India. Its appearance in other countries is inevitable.

There is a new variant of COVID-19. In a few weeks, it may also take its toll in Poland.
There is a new variant of COVID-19. In a few weeks, it may also take its toll in Poland.
Images source: © PAP | JOEL CARRETT

20 September 2024 10:47

The British "Independent" reported on Wednesday that XEC was detected in over 500 samples collected for testing. This new subvariant has also been detected in China, the USA, and Europe.

As BBC News warns, this subvariant might become dominant in a few weeks.

A new viral scourge is on the horizon. COVID-19 subvariant already circulating in Europe

It has already been found in Norway, Ukraine, and Germany. Meanwhile, experts in Poland have not confirmed the detection of this variant. The new subvariant of the SARS-CoV-2 virus is one of the Omicron strains, which present through subsequent subvariants. Currently, the most common subvariant in many countries is KP.3.1.1.

However, it is expected that XEC will soon dominate. The new subvariant, as announced on platform X by Mike Honey from Melbourne, Australia, a COVID-19 data analyst, is spreading quite rapidly and looks like a potential new competitor to KP.3.1.1.

Professor Eric Topol, director of the Scripps Research Translation Institute, shares this opinion. In a statement to the Los Angeles Times, he predicts that XEC will start to dominate in a few weeks, at the latest in a few months.

XEC's symptoms are similar to those of previous variants. They can include fever, sore throat, cough, loss of smell, loss of appetite, diarrhoea, and nausea. Importantly, the vaccines currently being introduced in the USA and the European Union are not targeted against XEC. They were designed to protect against the previously dominant Omicron subvariants.

Related content
© Daily Wrap
·

Downloading, reproduction, storage, or any other use of content available on this website—regardless of its nature and form of expression (in particular, but not limited to verbal, verbal-musical, musical, audiovisual, audio, textual, graphic, and the data and information contained therein, databases and the data contained therein) and its form (e.g., literary, journalistic, scientific, cartographic, computer programs, visual arts, photographic)—requires prior and explicit consent from Wirtualna Polska Media Spółka Akcyjna, headquartered in Warsaw, the owner of this website, regardless of the method of exploration and the technique used (manual or automated, including the use of machine learning or artificial intelligence programs). The above restriction does not apply solely to facilitate their search by internet search engines and uses within contractual relations or permitted use as specified by applicable law.Detailed information regarding this notice can be found  here.